REGENXBIO Future Growth
Future criteria checks 2/6
REGENXBIO is forecast to grow earnings and revenue by 35.5% and 40.8% per annum respectively. EPS is expected to grow by 42% per annum. Return on equity is forecast to be 2.7% in 3 years.
Key information
35.5%
Earnings growth rate
42.0%
EPS growth rate
Biotechs earnings growth | 30.9% |
Revenue growth rate | 40.8% |
Future return on equity | 2.7% |
Analyst coverage | Good |
Last updated | 11 Mar 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 274 | -103 | -1 | N/A | 8 |
12/31/2025 | 218 | -134 | -24 | -149 | 11 |
12/31/2024 | 134 | -211 | -152 | -202 | 11 |
12/31/2023 | 90 | -263 | -228 | -218 | N/A |
9/30/2023 | 99 | -261 | -231 | -217 | N/A |
6/30/2023 | 97 | -274 | -236 | -218 | N/A |
3/31/2023 | 110 | -270 | -257 | -232 | N/A |
12/31/2022 | 113 | -280 | -238 | -207 | N/A |
9/30/2022 | 480 | 74 | 134 | 173 | N/A |
6/30/2022 | 484 | 91 | 128 | 181 | N/A |
3/31/2022 | 474 | 101 | 143 | 207 | N/A |
12/31/2021 | 470 | 128 | 135 | 219 | N/A |
9/30/2021 | 93 | -212 | -166 | -83 | N/A |
6/30/2021 | 161 | -145 | -147 | -77 | N/A |
3/31/2021 | 156 | -121 | -116 | -63 | N/A |
12/31/2020 | 155 | -111 | -81 | -54 | N/A |
9/30/2020 | 145 | -91 | -134 | -119 | N/A |
6/30/2020 | 61 | -135 | -123 | -112 | N/A |
3/31/2020 | 52 | -103 | -128 | -114 | N/A |
12/31/2019 | 35 | -95 | -119 | -108 | N/A |
9/30/2019 | 64 | -64 | -102 | -86 | N/A |
6/30/2019 | 55 | -49 | -93 | -77 | N/A |
3/31/2019 | 87 | -37 | 4 | 17 | N/A |
12/31/2018 | 219 | 100 | 91 | 105 | N/A |
9/30/2018 | 180 | 80 | 84 | 95 | N/A |
6/30/2018 | 176 | 78 | 90 | 97 | N/A |
3/31/2018 | 142 | 53 | 11 | 18 | N/A |
12/31/2017 | 10 | -73 | -65 | -58 | N/A |
9/30/2017 | 10 | -77 | N/A | -65 | N/A |
6/30/2017 | 9 | -74 | N/A | -59 | N/A |
3/31/2017 | 5 | -74 | N/A | -58 | N/A |
12/31/2016 | 5 | -63 | N/A | -49 | N/A |
9/30/2016 | 7 | -49 | N/A | -33 | N/A |
6/30/2016 | 8 | -38 | N/A | -29 | N/A |
3/31/2016 | 7 | -32 | N/A | -29 | N/A |
12/31/2015 | 8 | -24 | N/A | -23 | N/A |
9/30/2015 | 4 | -21 | N/A | -18 | N/A |
6/30/2015 | 4 | -16 | N/A | -13 | N/A |
3/31/2015 | 4 | -8 | N/A | -5 | N/A |
12/31/2014 | 6 | -5 | N/A | -2 | N/A |
12/31/2013 | 6 | -6 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RB0 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RB0 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RB0 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RB0's revenue (40.8% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: RB0's revenue (40.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RB0's Return on Equity is forecast to be low in 3 years time (2.7%).